IL234635B - Purification of cystathionine beta-synthase - Google Patents

Purification of cystathionine beta-synthase

Info

Publication number
IL234635B
IL234635B IL234635A IL23463514A IL234635B IL 234635 B IL234635 B IL 234635B IL 234635 A IL234635 A IL 234635A IL 23463514 A IL23463514 A IL 23463514A IL 234635 B IL234635 B IL 234635B
Authority
IL
Israel
Prior art keywords
synthase
purification
cystathionine beta
cystathionine
beta
Prior art date
Application number
IL234635A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of IL234635B publication Critical patent/IL234635B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51Lyases (4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804Affinity chromatography
    • B01D15/3823Affinity chromatography of other types, e.g. avidin, streptavidin or biotin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/01Hydro-lyases (4.2.1)
    • C12Y402/01022Cystathionine beta-synthase (4.2.1.22)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL234635A 2012-03-26 2014-09-14 Purification of cystathionine beta-synthase IL234635B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615629P 2012-03-26 2012-03-26
US13/830,494 US9243239B2 (en) 2012-03-26 2013-03-14 Purification of cystathionine beta-synthase
PCT/US2013/033716 WO2013148580A1 (en) 2012-03-26 2013-03-25 Purification of cystathionine beta-synthase

Publications (1)

Publication Number Publication Date
IL234635B true IL234635B (en) 2018-12-31

Family

ID=49212017

Family Applications (2)

Application Number Title Priority Date Filing Date
IL234635A IL234635B (en) 2012-03-26 2014-09-14 Purification of cystathionine beta-synthase
IL26316218A IL263162B (en) 2012-03-26 2018-11-21 Purification of cystathionine beta-synthase

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL26316218A IL263162B (en) 2012-03-26 2018-11-21 Purification of cystathionine beta-synthase

Country Status (11)

Country Link
US (4) US9243239B2 (enExample)
EP (3) EP3569706A1 (enExample)
JP (3) JP6146934B2 (enExample)
CN (1) CN104540940B (enExample)
AU (1) AU2013240003B2 (enExample)
BR (1) BR112014023570B1 (enExample)
CA (1) CA2867719C (enExample)
HK (1) HK1246350B (enExample)
IL (2) IL234635B (enExample)
IN (1) IN2014DN07920A (enExample)
WO (1) WO2013148580A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034318B2 (en) 2011-08-30 2015-05-19 The Regents Of The University Of Colorado, A Body Corporate Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
HRP20220407T1 (hr) 2015-11-09 2022-05-27 The Regents Of The University Of Colorado, A Body Corporate Pripravci i postupci za uporabu u liječenju homocistinurije
MX2019012347A (es) 2017-04-17 2020-01-15 Univ Colorado Regents Optimizacion de terapia de reemplazo enzimatico para el tratamiento de la homocistinuria.
WO2020264061A1 (en) * 2019-06-25 2020-12-30 Zymergen Inc. Engineered biosynthetic pathways for production of cystathionine by fermentation
FI3990005T3 (fi) 2019-06-26 2025-11-28 Travere Therapeutics Switzerland Gmbh Pegyloitu kystationiini-beta-syntaasi entsyymihoitoa varten homokystinurian hoitamiseksi

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576559A (en) 1978-12-01 1980-06-09 Chiyou Lsi Gijutsu Kenkyu Kumiai Electron beam fine adjusting device
US5523225A (en) 1993-09-13 1996-06-04 Regents Of The University Of Colorado DNA sequence encoding human cystathionine β-synthase
US5635375A (en) 1995-01-09 1997-06-03 Regents Of The University Of Colorado Method of increasing the yield and heme saturation of cystathione β-synthase
AU2003251550A1 (en) 2002-06-17 2003-12-31 The Regents Of The University Of Colorado HUMAN CYSTATHIONINE Beta-SYNTHASE VARIANTS AND METHODS OF PRODU CTION THEREOF
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
EP1396537A1 (en) 2002-09-04 2004-03-10 Avidis SA Treatment of elevated plasma homocysteine
CN1552905A (zh) * 2003-12-18 2004-12-08 中国农业科学院茶叶研究所 一类茶树胱硫醚-γ-合成酶特异表达序列标签及其生物芯片
EP1878739A1 (en) 2006-07-14 2008-01-16 LEK Pharmaceuticals D.D. One step IMAC (MCAC) purification of proteins
WO2011097381A2 (en) 2010-02-04 2011-08-11 The Board Of Regents Of Use University Of Texas System Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase

Also Published As

Publication number Publication date
US20160177287A1 (en) 2016-06-23
CN104540940B (zh) 2018-03-06
US20130251700A1 (en) 2013-09-26
CA2867719C (en) 2020-08-11
EP2831229B1 (en) 2017-10-18
US10160962B2 (en) 2018-12-25
EP3263701A1 (en) 2018-01-03
US20190055537A1 (en) 2019-02-21
JP6839595B2 (ja) 2021-03-10
EP2831229A1 (en) 2015-02-04
JP2017121255A (ja) 2017-07-13
WO2013148580A1 (en) 2013-10-03
JP2015512639A (ja) 2015-04-30
US9243239B2 (en) 2016-01-26
US20200131497A1 (en) 2020-04-30
HK1246350B (en) 2020-05-15
EP3263701B1 (en) 2019-06-19
AU2013240003A1 (en) 2014-10-02
EP2831229B8 (en) 2018-10-17
JP6146934B2 (ja) 2017-06-21
AU2013240003B2 (en) 2018-04-19
US10941392B2 (en) 2021-03-09
JP6952361B2 (ja) 2021-10-20
IL263162B (en) 2019-11-28
EP3569706A1 (en) 2019-11-20
BR112014023570B1 (pt) 2022-03-15
BR112014023570A2 (pt) 2021-06-01
IN2014DN07920A (enExample) 2015-05-01
CN104540940A (zh) 2015-04-22
IL263162A (en) 2018-12-31
JP2020000259A (ja) 2020-01-09
CA2867719A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
IL287057A (en) Purified iduronate-2-sulfatase
IL238578B (en) Spliceostatin analogs
SG11201405573WA (en) Production of graphene
IL263162B (en) Purification of cystathionine beta-synthase
ZA201406082B (en) Use of ccr3-inhibitors
SG11201403891SA (en) Purification of flaviviruses
SG11201406800UA (en) Purification of air
GB201501016D0 (en) Preparation of 18F-fluciclovine
GB201209082D0 (en) Purification method
PL2832243T3 (pl) Odcięty fragment arkusza zawierającego zapach
LT2807172T (lt) Pirimidooksazocino dariniai kaip mtor slopikliai
HRP20150833T1 (en) Water-power of screw type
GB2507762B (en) Improvements to dartboards
AU5382P (en) HI01 Pittosporum tenuifolium
GB201203494D0 (en) Hydrophobin purification
TWM433525U (en) Structure of calorifier
GB201204173D0 (en) Water purification
EP2814499A4 (en) PURIFICATION PROCESS
GB201201142D0 (en) Sdd
GB201207154D0 (en) Novel form
GB201212393D0 (en) Novel combination
GB201207948D0 (en) Management - television show series
GB201204590D0 (en) Prodrugs of thiazolamine compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed